Additionally, three did not achieve an MFI below 5,000 (patient 4, 7,176; patient 8, 6,339; patient 10, 6,336); however, all showed a decreasing trend and it was anticipated that their levels would reach the target by the day of transplantation, allowing the procedures to proceed.
← all excerpts
Clinical outcomes of bortezomib-based desensitization in highly sensitized living and deceased donor kidney transplantation.
1
—
—